Literature DB >> 19559011

ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell line.

Yideng Liang1, Haibing Jiang, Tamara Ratovitski, Chunfa Jie, Masayuki Nakamura, Ricky R Hirschhorn, Xiaofang Wang, Wanli W Smith, Tsonwin Hai, Michelle A Poirier, Christopher A Ross.   

Abstract

Huntington's disease is a progressive neurodegenerative disorder caused by a polyglutamine expansion near the N-terminus of huntingtin. The mechanisms of polyglutamine neurotoxicity, and cellular responses are not fully understood. We have studied gene expression profiles by short oligo array using an inducible PC12 cell model expressing an N-terminal huntingtin fragment with expanded polyglutamine (Htt-N63-148Q). Mutant huntingtin Htt-N63 induced cell death and increased the mRNA and protein levels of activating transcription factor 3 (ATF3). Mutant Htt-N63 also significantly enhanced ATF3 transcriptional activity by a promoter-based reporter assay. Overexpression of ATF3 protects against mutant Htt-N63 toxicity and knocking down ATF3 expression reduced Htt-N63 toxicity in a stable PC12 cell line. These results indicated that ATF3 plays a critical role in toxicity induced by mutant Htt-N63 and may lead to a useful therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559011      PMCID: PMC2765721          DOI: 10.1016/j.brainres.2009.06.049

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  43 in total

1.  On parametric empirical Bayes methods for comparing multiple groups using replicated gene expression profiles.

Authors:  C M Kendziorski; M A Newton; H Lan; M N Gould
Journal:  Stat Med       Date:  2003-12-30       Impact factor: 2.373

2.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

Review 3.  Transcriptional abnormalities in Huntington disease.

Authors:  Katharine L Sugars; David C Rubinsztein
Journal:  Trends Genet       Date:  2003-05       Impact factor: 11.639

4.  Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.

Authors:  Ruth Luthi-Carter; Andrew D Strand; Sarah A Hanson; Charles Kooperberg; Gabriele Schilling; Albert R La Spada; Diane E Merry; Anne B Young; Christopher A Ross; David R Borchelt; James M Olson
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

5.  Expression of the activating transcription factor 3 prevents c-Jun N-terminal kinase-induced neuronal death by promoting heat shock protein 27 expression and Akt activation.

Authors:  Saya Nakagomi; Yasuhiro Suzuki; Kazuhiko Namikawa; Sumiko Kiryu-Seo; Hiroshi Kiyama
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

6.  Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein.

Authors:  Haibing Jiang; Frederick C Nucifora; Christopher A Ross; Donald B DeFranco
Journal:  Hum Mol Genet       Date:  2003-01-01       Impact factor: 6.150

7.  CRE-mediated transcription is increased in Huntington's disease transgenic mice.

Authors:  Karl Obrietan; Kari R Hoyt
Journal:  J Neurosci       Date:  2004-01-28       Impact factor: 6.167

8.  Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators.

Authors:  Michael L Major; Rita Lepe; Robert H Costa
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation.

Authors:  Shuichi Igarashi; Hokuto Morita; Kyla M Bennett; Yuji Tanaka; Simone Engelender; Matthew F Peters; Jillian K Cooper; Jonathan D Wood; Akira Sawa; Christopher A Ross
Journal:  Neuroreport       Date:  2003-03-24       Impact factor: 1.837

10.  Differential usage of alternate promoters of the human stress response gene ATF3 in stress response and cancer cells.

Authors:  Keisuke Miyazaki; Shoko Inoue; Kazuhiko Yamada; Masashi Watanabe; Qin Liu; Toshiki Watanabe; Mimi Tamamori Adachi; Yujiro Tanaka; Shigetaka Kitajima
Journal:  Nucleic Acids Res       Date:  2009-01-09       Impact factor: 16.971

View more
  5 in total

1.  ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation.

Authors:  Rhona Seijffers; Jiangwen Zhang; Jonathan C Matthews; Adam Chen; Eric Tamrazian; Olusegun Babaniyi; Martin Selig; Meri Hynynen; Clifford J Woolf; Robert H Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

2.  Activating transcription factor 3 and the nervous system.

Authors:  David Hunt; Gennadij Raivich; Patrick Norval Anderson
Journal:  Front Mol Neurosci       Date:  2012-02-14       Impact factor: 5.639

3.  Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.

Authors:  Ravi S Akundi; Zhenyu Huang; Joshua Eason; Jignesh D Pandya; Lianteng Zhi; Wayne A Cass; Patrick G Sullivan; Hansruedi Büeler
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

Review 4.  Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective.

Authors:  Luis M Valor
Journal:  Mol Neurobiol       Date:  2014-05-01       Impact factor: 5.590

5.  Large-scale RNA interference screening in mammalian cells identifies novel regulators of mutant huntingtin aggregation.

Authors:  Tomoyuki Yamanaka; Hon Kit Wong; Asako Tosaki; Peter O Bauer; Koji Wada; Masaru Kurosawa; Tomomi Shimogori; Nobutaka Hattori; Nobuyuki Nukina
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.